| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 13 Nov 2025 | ICICI Securities | Sell | ₹629.5 | ₹640 | 7.3% | moneycontrol | View |
| 29 May 2025 | ICICI Securities | Buy | ₹1,107.75 | ₹1,365 | 27.9% | moneycontrol | View |
| 25 Mar 2025 | ICICI Securities | Buy | ₹1,173.95 | ₹1,400 | 21.6% | moneycontrol | View |
| 29 Feb 2024 | Geofin Comtrade | Sell | ₹630.9 | ₹571 | -55.7% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| Cohance Lifesciences Limited | NA | NA | NA | 2.46 | 33,257 | 94.6 |
| Aster DM Healthcare Limited | 7264.5 | 1046.1 | 6818.1 | 2.03 | 32388 | 91.6 |
| Gland Pharma Limited | 11567.44 | 3019.95 | 10741.52 | 18.33 | 32261 | 41.9 |
SUVEN PHARMACEUTICALS LIMITED, with Security Code 543064, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 212.8 | 243.5 | 222.1 | 236.1 | 275.4 | 330.2 | 483.6 | 0.0 |
| Expenses | 144.7 | 171.4 | 139.1 | 135.1 | 159.9 | 262.9 | 379.4 | -36.4 |
| Operating Profit | 68.1 | 72.1 | 83.0 | 101.0 | 115.5 | 67.3 | 104.2 | 36.4 |
| OPM % | 32.02% | 29.63% | 37.39% | 42.79% | 41.93% | 20.37% | 21.55% | 0% |
| Other Income | 14.0 | 16.9 | 18.0 | 13.4 | 15.2 | 6.6 | 5.0 | 0.0 |
| Interest | 1.3 | 2.3 | 1.6 | 1.5 | 2.6 | 2.3 | 6.8 | 5.2 |
| Depreciation | 11.3 | 15.7 | 12.0 | 12.3 | 13.4 | 15.2 | 31.4 | 31.2 |
| Profit before tax | 69.5 | 71.1 | 87.4 | 100.7 | 114.6 | 56.4 | 79.1 | 0.0 |
| Tax % | -24.7% | -24.8% | -25.5% | -24.2% | -24.7% | -21.1% | 26% | 0% |
| Net Profit | 52.4 | 53.4 | 65.1 | 76.3 | 86.4 | 44.3 | 52.6 | 0.0 |
| EPS in Rs | 2.06 | 2.1 | 2.56 | 2.98 | 3.37 | 0 | 1.37 | 0 |
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 347.6 | 231.1 | 219.8 | 252.9 | 230.7 | 257.7 | 307.2 | 402.0 |
| Expenses | 180.6 | 133.1 | 154.7 | 179.6 | 150.8 | 153.7 | 189.5 | 328.4 |
| Operating Profit | 167.0 | 98.0 | 65.1 | 73.3 | 79.9 | 104.0 | 117.7 | 73.7 |
| OPM % | 48.04% | 42.4% | 29.64% | 29% | 34.64% | 40.36% | 38.32% | 18.32% |
| Other Income | 10.7 | 19.8 | 14.3 | 17.1 | 18.2 | 14.1 | 15.7 | 10.6 |
| Interest | 1.1 | 0.5 | 1.3 | 2.3 | 1.6 | 1.7 | 3.3 | 5.8 |
| Depreciation | 12.5 | 11.9 | 12.8 | 17.2 | 13.4 | 17.0 | 20.4 | 26.8 |
| Profit before tax | 163.9 | 105.4 | 65.5 | 70.9 | 83.1 | 99.5 | 109.7 | 51.7 |
| Tax % | -26.4% | -24.5% | -28.6% | -24.7% | 26.9% | 17.6% | 24.1% | -24.8% |
| Net Profit | 120.6 | 79.6 | 46.8 | 53.4 | 60.8 | 82.0 | 83.3 | 38.7 |
| EPS in Rs | 4.74 | 3.13 | 1.84 | 2.1 | 2.39 | 3.21 | 3.23 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 1% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 20% |
| 3 Years: | -4% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 46% |
| 3 Years: | 27% |
| 1 Year: | 71% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 23% |
| 3 Years: | 1% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 20% |
| 3 Years: | -9% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 46% |
| 3 Years: | 27% |
| 1 Year: | 71% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|